Your browser doesn't support javascript.
loading
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.
Berte, Nancy; Piée-Staffa, Andrea; Piecha, Nadine; Wang, Mengwan; Borgmann, Kerstin; Kaina, Bernd; Nikolova, Teodora.
Afiliação
  • Berte N; Institute of Toxicology, University Medical Center Mainz, Mainz, Germany.
  • Piée-Staffa A; Institute of Toxicology, University Medical Center Mainz, Mainz, Germany.
  • Piecha N; Institute of Toxicology, University Medical Center Mainz, Mainz, Germany.
  • Wang M; Institute of Toxicology, University Medical Center Mainz, Mainz, Germany.
  • Borgmann K; Laboratory of Radiobiology & Experimental Radiooncology, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kaina B; Institute of Toxicology, University Medical Center Mainz, Mainz, Germany. kaina@uni-mainz.de nikolova@uni-mainz.de.
  • Nikolova T; Institute of Toxicology, University Medical Center Mainz, Mainz, Germany. kaina@uni-mainz.de nikolova@uni-mainz.de.
Mol Cancer Ther ; 15(11): 2665-2678, 2016 11.
Article em En | MEDLINE | ID: mdl-27474153
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Recombinação Homóloga Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Recombinação Homóloga Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2016 Tipo de documento: Article